In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer

Cancer Genetics and Cytogenetics

Volumn 160, Issue 1, 2005, Pages 35-42

  Israeli, Ofir ^a,c   Goldring Aviram, Ayala ^a,c   Rienstein, Shlomit ^a   Ben Baruch, Gilad ^b,c   Korach, Jakob ^b   Goldman, Boleslaow ^a,c   Friedman, Eitan ^a,c  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA DETERMINATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE IDENTIFICATION; GENOMICS; HUMAN; OVARY CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL;

CHROMOSOME MAPPING; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; HUMANS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS;

EID: 20444409161     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.11.011     Document Type: Article

References (69)

1. W. Gajewski, and R.D. Legare Ovarian cancer Surg Oncol Clin N Am 7 1998 317 331
2. American Cancer Society Cancer facts and figures 2003 American Cancer Society, Inc. Atlanta, GA pp. 15-6
3. J.S. Berek Interval debulking of ovarian cancer - an interim measure N Engl J Med 332 1995 675 677
4. G. Gatta, M.B. Lasota, and A. Verdecchia Survival of European women with gynaecological tumours, during the period 1978-1989. EUROCARE Working Group Eur J Cancer 34 1998 2218 2225
5. J. Engel, R. Eckel, G. Schubert-Fritschle, J. Kerr, W. Kuhn, J. Diebold, R. Kimmig, J. Rehbock, and D. Holzel Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate Eur J Cancer 38 2002 2435 2445
6. D.J. Duggan, M. Bittner, Y. Chen, P. Meltzer, and J.M. Trent Expression profiling using cDNA microarrays Nat Genet 21 1999 10 14
7. M. Schena, R.A. Heller, T.P. Theriault, K. Konrad, E. Lachenmeier, and R.W. Davis Microarrays: biotechnology's discovery platform for functional genomics Trends Biotechnol 16 1998 301 306
8. F. Bertucci, P. Viens, R. Tagett, C. Nguyen, R. Houlgatte, and D. Birnbaum DNA arrays in clinical oncology: promises and challenges Lab Invest 83 2003 305 316
9. J.C. Mills, K.A. Roth, R.L. Cagan, and J.I. Gordon DNA microarrays and beyond: completing the journey from tissue to cell Nat Cell Biol 3 2001 175 178
10. A. Butte The use and analysis of microarray data Natl Rev Drug Discov 1 2002 951 960
11. S. Struski, M. Doco-Fenzy, and P. Cornillet-Lefebvre Compilation of published comparative genomic hybridization studies Cancer Genet Cytogenet 135 2002 63 90
12. D.R. Schwartz, S.L. Kardia, K.A. Shedden, R. Kuick, G. Michailidis, J.M. Taylor, D.E. Misek, R. Wu, Y. Zhai, D.M. Darrah, H. Reed, L.H. Ellenson, T.J. Giordano, E.R. Fearon, S.M. Hanash, and K.R. Cho Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas Cancer Res 62 2002 4722 4729
13. T.R. Adib, S. Henderson, C. Perrett, D. Hewitt, D. Bourmpoulia, J. Ledermann, and C. Boshoff Predicting biomarkers for ovarian cancer using gene-expression microarrays Br J Cancer 90 2004 686 692
14. J. Bayani, J.D. Brenton, P.F. Macgregor, B. Beheshti, M. Albert, D. Nallainathan, J. Karaskova, B. Rosen, J. Murphy, S. Laframboise, B. Zanke, and J.A. Squire Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays Cancer Res 62 2002 3466 3476
15. T.J. Giordano, K.A. Shedden, D.R. Schwartz, R. Kuick, J.M. Taylor, N. Lee, D.E. Misek, J.K. Greenson, S.L. Kardia, D.G. Beer, G. Rennert, K.R. Cho, S.B. Gruber, E.R. Fearon, and S. Hanash Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles Am J Pathol 159 2001 1231 1238
16. R.S. Ismail, R.L. Baldwin, J. Fang, D. Browning, B.Y. Karlan, J.C. Gasson, and D.D. Chang Differential gene expression between normal and tumor-derived ovarian epithelial cells Cancer Res 60 2000 6744 6749
17. A.A. Jazaeri, K. Lu, R. Schmandt, C.P. Harris, P.H. Rao, C. Sotiriou, G.V. Chandramouli, D.M. Gershenson, and E.T. Liu Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma Mol Carcinog 36 2003 53 59
18. A.A. Jazaeri, C.J. Yee, C. Sotiriou, K.R. Brantley, J. Boyd, and E.T. Liu Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers J Natl Cancer Inst 94 2002 990 1000
19. J.M. Lancaster, H.K. Dressman, R.S. Whitaker, L. Havrilesky, J. Gray, J.R. Marks, J.R. Nevins, and A. Berchuck Gene expression patterns that characterize advanced stage serous ovarian cancers J Soc Gynecol Investig 11 2004 51 59
20. D. Matei, T.G. Graeber, R.L. Baldwin, B.Y. Karlan, J. Rao, and D.D. Chang Gene expression in epithelial ovarian carcinoma Oncogene 21 2002 6289 6298
21. K. Ono, T. Tanaka, T. Tsunoda, O. Kitahara, C. Kihara, A. Okamoto, K. Ochiai, T. Takagi, and Y. Nakamura Identification by cDNA microarray of genes involved in ovarian carcinogenesis Cancer Res 60 2000 5007 5011
22. G.P. Sawiris, C.A. Sherman-Baust, K.G. Becker, C. Cheadle, D. Teichberg, and P.J. Morin Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer Cancer Res 62 2002 2923 2928
23. M.E. Schaner, D.T. Ross, G. Ciaravino, T. Sorlie, O. Troyanskaya, M. Diehn, Y.C. Wang, G.E. Duran, T.L. Sikic, S. Caldeira, H. Skomedal, I.P. Tu, T. Hernandez-Boussard, S.W. Johnson, P.J. O'Dwyer, M.J. Fero, G.B. Kristensen, A.L. Borresen-Dale, T. Hastie, R. Tibshirani, M. van de Rijn, N.N. Teng, T.A. Longacre, D. Botstein, P.O. Brown, and B.I. Sikic Gene expression patterns in ovarian carcinomas Mol Biol Cell 14 2003 4376 4386
24. M. Schummer, W.V. Ng, R.E. Bumgarner, P.S. Nelson, B. Schummer, D.W. Bednarski, L. Hassell, R.L. Baldwin, B.Y. Karlan, and L. Hood Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas Gene 238 1999 375 385
25. V. Shridhar, A. Sen, J. Chien, J. Staub, R. Avula, S. Kovats, J. Lee, J. Lillie, and D.I. Smith Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization Cancer Res 62 2002 262 270
26. V. Shridhar, J. Lee, A. Pandita, S. Iturria, R. Avula, J. Staub, M. Morrissey, E. Calhoun, A. Sen, K. Kalli, G. Keeney, P. Roche, W. Cliby, K. Lu, R. Schmandt, G.B. Mills, R.C. Bast Jr., C.D. James, F.J. Couch, L.C. Hartmann, J. Lillie, and D.I. Smith Genetic analysis of early- versus late-stage ovarian tumors Cancer Res 61 2001 5895 5904
27. A.I. Su, J.B. Welsh, L.M. Sapinoso, S.G. Kern, P. Dimitrov, H. Lapp, P.G. Schultz, S.M. Powell, C.A. Moskaluk, H.F. Frierson Jr., and G.M. Hampton Molecular classification of human carcinomas by use of gene expression signatures Cancer Res 61 2001 7388 7393
28. K. Wang, L. Gan, E. Jeffery, M. Gayle, A.M. Gown, M. Skelly, P.S. Nelson, W.V. Ng, M. Schummer, L. Hood, and J. Mulligan Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray Gene 229 1999 101 108
29. J.B. Welsh, P.P. Zarrinkar, L.M. Sapinoso, S.G. Kern, C.A. Behling, B.J. Monk, D.J. Lockhart, R.A. Burger, and G.M. Hampton Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer Proc Natl Acad Sci USA 98 2001 1176 1181
30. V.M. Wasenius, A. Jekunen, O. Monni, H. Joensuu, S. Aebi, S.B. Howell, and S. Knuutila Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells Genes Chromosomes Cancer 18 1997 286 291
31. G. Sonoda, J. Palazzo, S. du Manoir, A.K. Godwin, M. Feder, M. Yakushiji, and J.R. Testa Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas Genes Chromosomes Cancer 20 1997 320 328
32. M.A. Riopel, A. Spellerberg, C.A. Griffin, and E.J. Perlman Genetic analysis of ovarian germ cell tumors by comparative genomic hybridization Cancer Res 58 1998 3105 3110
33. N.G. Wolf, F.W. Abdul-Karim, C. Farver, E. Schrock, S. du Manoir, and S. Schwartz Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization Genes Chromosomes Cancer 25 1999 307 315
34. Y. Suehiro, M. Sakamoto, K. Umayahara, H. Iwabuchi, H. Sakamoto, N. Tanaka, N. Takeshima, K. Yamauchi, K. Hasumi, T. Akiya, H. Sakunaga, T. Muroya, F. Numa, H. Kato, Y. Tenjin, and T. Sugishita Genetic aberrations detected by comparative genomic hybridization in ovarian clear cell adenocarcinomas Oncology 59 2000 50 56
35. V. Shridhar, J. Lee, A. Pandita, S. Iturria, R. Avula, J. Staub, M. Morrissey, E. Calhoun, A. Sen, K. Kalli, G. Keeney, P. Roche, W. Cliby, K. Lu, R. Schmandt, G.B. Mills, R.C. Bast Jr., C.D. James, F.J. Couch, L.C. Hartmann, J. Lillie, and D.I. Smith Genetic analysis of early- versus late-stage ovarian tumors Cancer Res 6 2001 5895 5904
36. L. Shayesteh, Y. Lu, W.L. Kuo, R. Baldocchi, T. Godfrey, C. Collins, D. Pinkel, B. Powell, G.B. Mills, and J.W. Gray PIK3CA is implicated as an oncogene in ovarian cancer Nat Genet 21 1999 99 102
37. J. Tapper, L. Sarantaus, P. Vahteristo, H. Nevanlinna, S. Hemmer, M. Seppala, S. Knuutila, and R. Butzow Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization: extensive similarity except for a difference at chromosome 2q24-q32 Cancer Res 58 1998 2715 2719
38. Y. Patael-Karasik, M. Daniely, W.H. Gotlieb, G. Ben-Baruch, J. Schiby, G. Barakai, B. Goldman, A. Aviram, and E. Friedman Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel Cancer Genet Cytogenet 121 2000 26 32
39. O. Israeli, W.H. Gotlieb, E. Friedman, B. Goldman, G. Ben-Baruch, A. Aviram-Goldring, and S. Rienstein Familial vs sporadic ovarian tumors: characteristic genomic alterations analyzed by CGH Gynecol Oncol 90 2003 629 636
40. C.C. Gu, D.C. Rao, G. Stormo, C. Hicks, and M.A. Province Role of gene expression microarray analysis in finding complex disease genes Genet Epidemiol 23 2002 37 56
41. R.B. Altman, and S. Raychaudhuri Whole-genome expression analysis: challenges beyond clustering Curr Opin Struct Biol 11 2001 340 347
42. Y. Shimizu, S. Kamoi, S. Amada, K. Hasumi, F. Akiyama, and S.G. Silverberg Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features - problems involved in the architectural grading system Gynecol Oncol 70 1998 2 12
43. M.L. Friedlander, and A.J. Dembo Prognostic factors in ovarian cancer Semin Oncol 18 1991 205 212
44. K.K. Zorn, A.A. Jazaeri, C.S. Awtrey, G.J. Gardner, S.C. Mok, J. Boyd, and M.J. Birrer Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies Clin Cancer Res 15 2003 4811 4818
45. S. Ranganathan, K.J. Simpson, D.C. Shaw, and K.R. Nicholas The whey acidic protein family: a new signature motif and three-dimensional structure by comparative modeling J Mol Graph Model 17 1999 134 136
46. J. Schalkwijk, O. Wiedow, and S. Hirose The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core Biochem J 340 1999 569 577
47. I. Hellstrom, J. Raycraft, M. Hayden-Ledbetter, J.A. Ledbetter, M. Schummer, M. McIntosh, C. Drescher, N. Urban, and K.E. Hellstrom The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma Cancer Res 63 2003 3695 3700
48. Z. He, and A. Bateman Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis J Mol Med 81 2003 600 612
49. K. Noben-Trauth, N.G. Copeland, D.J. Gilbert, N.A. Jenkins, G. Sonoda, J.R. Testa, and K.H. Klempnauer Mybl2 (Bmyb) maps to mouse chromosome 2 and human chromosome 20q 13.1 Genomics 35 1996 610 612
50. M.M. Tanner, M. Tirkkonen, A. Kallioniemi, K. Holli, C. Collins, D. Kowbel, J.W. Gray, O.P. Kallioniemi, and J. Isola Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications Clin Cancer Res 1 1995 1455 1461
51. J. Kononen, L. Bubendorf, A. Kallioniemi, M. Barlund, P. Schraml, S. Leighton, J. Torhorst, M.J. Mihatsch, G. Sauter, and O.P. Kallioniemi Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 1998 844 847
52. F.M. Townsley, A. Aristarkhov, S. Beck, A. Hershko, and J.V. Ruderman Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase Proc Natl Acad Sci USA 94 1997 2362 2367
53. S. Shafti-Keramat, A. Handisurya, E. Kriehuber, G. Meneguzzi, K. Slupetzky, and R. Kirnbauer Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses J Virol 77 2003 13125 13135
54. C.K. Thodeti, R. Albrechtsen, M. Grauslund, M. Asmar, C. Larsson, Y. Takada, A.M. Mercurio, J.R. Couchman, and U.M. Wewer ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA J Biol Chem 278 2003 9576 9584
55. Y. Tamada, S. Iida, D. Aoki, S. Nozawa, and T. Irimura Carbohydrate epitopes and mucins expressed by 17 human ovarian carcinoma cell lines Oncol Res 11 1999 233 241
56. F. Boman, M.P. Buisine, A. Wacrenier, D. Querleu, J.P. Aubert, and N. Porchet Mucin gene transcripts in benign and borderline mucinous tumours of the ovary: an in situ hybridization study J Pathol 193 2001 339 344
57. H. Feng, M. Ghazizadeh, H. Konishi, and T. Araki Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas Jpn J Clin Oncol 32 2002 525 529
58. C.A. Reis, L. David, M. Seixas, J. Burchell, and M. Sobrinho-Simoes Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma Int. J Cancer 79 1998 402 410
59. E.C. Mommers, A.M. Leonhart, S. von Mensdorff-Pouilly, D.J. Schol, J. Hilgers, C.J. Meijer, J.P. Baak, and P.J. van Diest Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma in situ of the breast Int J Cancer 84 1999 466 469
60. G. Riethmuller, E. Holz, G. Schlimok, W. Schmiegel, R. Raab, K. Hoffken, R. Gruber, I. Funke, H. Pichlmaier, H. Hirche, P. Buggisch, J. Witte, and R. Pichlmayr Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial J Clin Oncol 16 1998 1788 1794
61. T.G. Kroll, P. Sarraf, L. Pecciarini, C.J. Chen, E. Mueller, B.M. Spiegelman, and J.A. Fletcher PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma Science 289 2000 1357 1360
62. K. Chang, and I. Pastan Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers Proc Natl Acad Sci USA 93 1996 136 140
63. N. Scholler, N. Fu, Y. Yang, Z. Ye, G.E. Goodman, K.E. Hellstrom, and I. Hellstrom Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma Proc Natl Acad Sci USA 96 1999 11531 11536
64. D. Steinbach, S. Viehmann, F. Zintl, and B. Gruhn PRAME gene expression in childhood acute lymphoblastic leukemia Cancer Genet Cytogenet 138 2002 89 91
65. U. Thorsteinsdottir, E. Kroon, L. Jerome, F. Blasi, and G. Sauvageau Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia Mol Cell Biol 21 2001 224 234
66. D.R. Alessi, C. Smythe, and S.M. Keyse The human CL100 gene encodes a tyr/thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts Oncogene 8 1993 2015 2020
67. S.M. Keyse, and E.A. Emslie Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase Nature 359 1992 644 647
68. J. Kim, L. Ashworth, E. Branscomb, and L. Stubbs The human homolog of a mouse-imprinted gene, Peg3, maps to a zinc finger gene-rich region of human chromosome 19q13.4 Genome Res 5 1997 532 540
69. F. Relaix, X. Wei, W. Li, J. Pan, Y. Lin, D.D. Bowtell, D.A. Sassoon, and X. Wu Pw1/Peg3 is a potential cell death mediator and cooperates with Siah1a in p53-mediated apoptosis Proc Natl Acad Sci USA 97 2000 2105 2110